130+Harvard students enter Noah ARK: an immersive dialogue about wealth, culture, and the future

130+Harvard students enter Noah ARK: an immersive dialogue about wealth, culture, and the future

SHANGHAI, May 30, 2025 /PRNewswire/ -- Recently, the Noah ARK DeepNOAH global talent development brand event "A WARM WELCOME TO HARVARD" was warmly held at the Noah Wealth N+Square. Mr. Pan Qing, CFO of Noah Holdings and CEO of ARK Hong Kong,...

The installed capacity of new energy in Turfan has surpassed 9 million kilowatts, accounting for 74.2% of the total installed capacity of power sources

The installed capacity of new energy in Turfan has surpassed 9 million kilowatts, accounting for 74.2% of the total installed capacity of power sources

TURFAN, China, May 29, 2025 /PRNewswire/ -- On May 29th, State Grid Turfan Power Supply Company announced that the installed capacity of new energy in Turfan reached 9.035 million kilowatts, representing 74.2% of the total installed capacity of...

FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 23, 2025 /PRNewswire/ -- Duality Biotherapeutics ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company...

Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic ‌Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS

Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic ‌Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS

YANTAI, China, May 12, 2025 /PRNewswire/ -- On May 12th, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that its phase 3 clinical trial (Study ID: RC48-C016) on disitamab vedotin (DV, brand name: 爱地希®), the first...

State Grid Bortala Electric Power Supply Company Ensures Smooth Railway Transport During the Spring Festival Travel Rush

State Grid Bortala Electric Power Supply Company Ensures Smooth Railway Transport During the Spring Festival Travel Rush

BORTALA, China, Jan. 22, 2025 /PRNewswire/ -- On January 20, State Grid Bortala Electric Power Supply Company organized a team of employees to conduct inspections on the 110 kV Huanggu transmission line, ensuring its safe and stable operation during...

Hetian Minfeng 220 kV Power Transmission and Transformation Project: comprehensive self-inspection and defect rectification work across the entire line initiated

Hetian Minfeng 220 kV Power Transmission and Transformation Project: comprehensive self-inspection and defect rectification work across the entire line initiated

HETIAN, China, Nov. 22, 2024 /PRNewswire/ -- On November 20, the 220kV transmission and transformation project in Minfeng County, Hetian, carried out a comprehensive self-inspection and defect rectification across the entire line. The line section...

2024 WIC & Light of Internet Expo Kicks off in Wuzhen, Zhejiang

2024 WIC & Light of Internet Expo Kicks off in Wuzhen, Zhejiang

WUZHEN, China, Nov. 21, 2024 /PRNewswire/ -- A news report from CRIOnline: The 2024 World Internet Conference & Light of Internet Expo (WICEXPO) kicked off in Wuzhen on November 19, 2024. As an important part of the World Internet Conference...

menu
menu